The pharmacokinetic profile of inhaled and oral salbutamol in elite athletes with asthma and nonasthmatic subjects.

@article{Elers2012ThePP,
  title={The pharmacokinetic profile of inhaled and oral salbutamol in elite athletes with asthma and nonasthmatic subjects.},
  author={Jimmi Elers and Lars Pedersen and John Henninge and Peter Hemmersbach and Kim Dalhoff and Vibeke Backer},
  journal={Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine},
  year={2012},
  volume={22 2},
  pages={140-5}
}
OBJECTIVE Data on pharmacokinetics of inhaled and oral salbutamol in elite athletes with asthma are needed to differentiate between therapeutic use and doping in doping control. DESIGN An interventional open-label crossover. SETTING Respiratory Research Unit, Copenhagen University Hospital, Bispebjerg. PARTICIPANTS Eight elite athletes with asthma and 10 nonasthmatic subjects aged 18 to 33 years. INTERVENTION Administration of 0.8 mg of inhaled salbutamol and 8 mg of oral salbutamol… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 7 times over the past 90 days. VIEW TWEETS